Palisade Bio (PALI) EBT Margin (2011 - 2023)
Palisade Bio (PALI) reported EBT Margin of 1011.6% for Q1 2023, up 99.26% on a QoQ basis from 137416.12% in Q4 2020.
Palisade Bio (PALI) has 11 years of EBT Margin data on file, last reported at 1011.6% in Q1 2023.
- Quarterly EBT Margin changed N/A year-over-year to 1011.6% in Q1 2023, while the trailing twelve-month figure through Dec 2023 was 5234.0% (changed N/A YoY) and the FY2023 annual result came in at 5234.0%, changed N/A from the prior year.
- EBT Margin rose to 1011.6% in Q1 2023 per PALI's latest filing, from 137416.12% in the prior quarter.
- Across five years, EBT Margin topped out at 1011.6% in Q1 2023 and bottomed at 137416.12% in Q4 2020.
- The 3-year median for EBT Margin is 73700.24% (2020), against an average of 67692.18%.
- Peak annual rise in EBT Margin reached 6429700 bps in 2020, while the deepest fall reached 5243968 bps in 2020.
- Tracing PALI's EBT Margin over 3 years: stood at 84976.44% in 2019, then slumped by 62 bps to 137416.12% in 2020, then soared by 99 bps to 1011.6% in 2023.
- Per Business Quant, the three latest PALI EBT Margin figures stand at 1011.6% (Q1 2023), 137416.12% (Q4 2020), and 73450.76% (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1,011.60% |
| Dec 31, 2020 | -137,416.12% |
| Sep 30, 2020 | -73,450.76% |
| Jun 30, 2020 | -73,700.24% |
| Mar 31, 2020 | -32,886.28% |
| Dec 31, 2019 | -84,976.44% |
| Sep 30, 2019 | -84,434.16% |
| Jun 30, 2019 | -24,170.71% |
| Mar 31, 2019 | -97,183.28% |
| Dec 31, 2018 | -71,377.00% |
| Sep 30, 2018 | -82,662.12% |
| Jun 30, 2018 | -793.75% |
| Mar 31, 2018 | -93,326.64% |
| Dec 31, 2017 | -893.05% |
| Sep 30, 2017 | -102,846.28% |
| Jun 30, 2017 | -168,797.84% |
| Mar 31, 2017 | -173,994.24% |
| Dec 31, 2016 | -66,623.67% |
| Sep 30, 2016 | -205,606.96% |
| Jun 30, 2016 | -165,729.72% |
| Mar 31, 2016 | -264,359.28% |
| Dec 31, 2015 | -190,990.44% |
| Sep 30, 2015 | -225,502.72% |
| Jun 30, 2015 | -217,508.44% |
| Mar 31, 2015 | -173,230.89% |
| Dec 31, 2014 | -108,387.93% |
| Sep 30, 2014 | -89,104.74% |
| Jun 30, 2014 | -77,828.64% |
| Mar 31, 2014 | -134,027.45% |
| Dec 31, 2013 | -127,908.48% |
| Sep 30, 2013 | -162,566.12% |
| Jun 30, 2013 | -146,329.52% |
| Mar 31, 2013 | -2,858.65% |
| Dec 31, 2012 | -108,607.32% |
| Sep 30, 2012 | -1,509.12% |
| Jun 30, 2012 | -3,041.77% |
| Mar 31, 2012 | -1,571.43% |
| Dec 31, 2011 | -890.09% |
| Sep 30, 2011 | -3,105.49% |